Verition Fund Management
KLRS

Verition Fund Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Verition Fund Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,775
Closed -$48.2K – 2624
2024
Q1 		$48.2K Buy
+2,775
New +$48.2K ﹤0.01% 2030
2023
Q4 		– Sell
-2,945
Closed -$146K – 2262
2023
Q3 		$146K Buy
+2,945
New +$146K ﹤0.01% 1706